Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment
- 21 January 2019
- book chapter
- review article
- Published by Elsevier BV
- Vol. 141, 213-253
- https://doi.org/10.1016/bs.acr.2018.12.005
Abstract
No abstract availableKeywords
This publication has 166 references indexed in Scilit:
- Systemic cancer therapy: achievements and challenges that lie aheadFrontiers in Pharmacology, 2013
- On the epigenetic origin of cancer stem cellsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
- Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor CellsCancer Cell, 2012
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin SignalingCancer Cell, 2011
- Transcription factor-mediated epigenetic regulation of cell growth and phenotype for biological control and cancerAdvances in Enzyme Regulation, 2010
- Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib MesylateCancer Cell, 2010
- Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cellsHepatology, 2009
- Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expressionCancer Immunology, Immunotherapy, 2008
- Immunosurveillance by Hematopoietic Progenitor Cells Trafficking through Blood, Lymph, and Peripheral TissuesCell, 2007
- The Epigenomics of CancerCell, 2007